In the UK, several GLP-1 receptor agonists are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA), each with specific indications: semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management), dulaglutide (Trulicity for type 2 diabetes), and liraglutide (Victoza for type 2 diabetes, Saxenda for weight management)
Second, dramatic liver fat clearance
These agents increase insulin sensitivity in the liver, fat, and muscle, which can help reverse metabolic strain
Importation is restricted unless clearly designated for laboratory or research use
According to Sarwer and Maccarone, scientists believe these shifts in mood are caused by how the drug changes the brain's central reward pathways by diminishing responses to the neurotransmitter dopamine
Histological examination of the caecum and colon showed a reduction in mucin and a substantial reduction in the proportion of O -acylated sialic acids, compared to control animals, as well as a loss of the normal patterning (Al Suhail et al